Skip to main content
. 2020 Jun 24;12(6):587. doi: 10.3390/pharmaceutics12060587

Figure 2.

Figure 2

Schematic structure of the skin with possible pathways of percutaneous permeation of nanocarriers: (a) the intercellular; (b) the follicular (appendages); or (c) the transcellular path.